Jaguar Health, Inc. (JAGX) Financials

JAGX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 45.4 million 44.0 million
2023-06-30 52.2 million 46.3 million
2023-03-31 56.9 million 49.3 million
2022-12-31 47.5 million 48.8 million

JAGX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -6.8 million 528000
2023-06-30 -9.1 million 527000
2023-03-31 -9.9 million 480000
2022-12-31 -6.8 million 497000

JAGX Net Income

No data available :(

JAGX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 3.2 million - 877000
2023-06-30 8.6 million - 1.0 million
2023-03-31 14.4 million - 1.1 million
2022-12-31 5.5 million - 1.2 million

JAGX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 20.7 million
2023-06-30 29.1 million
2023-03-31 5.1 million
2022-12-31 1.3 million

JAGX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 6.1 million 4.4 million 637000
2023-06-30 - 4.3 million 5.1 million 878000
2023-03-31 - 4.8 million 4.8 million 1.9 million
2022-12-31 361000 4.3 million 3.0 million 1.7 million

JAGX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 2.8 million 514000
2023-06-30 2.7 million 491000
2023-03-31 2.0 million 345000
2022-12-31 3.3 million 495000

JAGX

Price: $0.18

52 week price:
0.05
1.22

Earnings Per Share: -0.87 USD

P/E Ratio: -0.11

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 617552

Ebitda: -16.5 million

Market Capitalization: 20.9 million

Links: